These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 25015687

  • 1. A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?
    Larance B, Carragher N, Mattick RP, Lintzeris N, Ali R, Degenhardt L.
    Drug Alcohol Depend; 2014 Sep 01; 142():46-55. PubMed ID: 25015687
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
    Holland R, Maskrey V, Swift L, Notley C, Robinson A, Nagar J, Gale T, Kouimtsidis C.
    Addiction; 2014 Apr 01; 109(4):596-607. PubMed ID: 24304349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The diversion and injection of a buprenorphine-naloxone soluble film formulation.
    Larance B, Lintzeris N, Ali R, Dietze P, Mattick R, Jenkinson R, White N, Degenhardt L.
    Drug Alcohol Depend; 2014 Mar 01; 136():21-7. PubMed ID: 24461476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI, King VL, Brooner RK, Rastegar DA.
    Subst Abus; 2014 Mar 01; 35(2):122-6. PubMed ID: 24821346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence.
    Coker JL, Catlin D, Ray-Griffith S, Knight B, Stowe ZN.
    Drug Alcohol Depend; 2018 Nov 01; 192():146-149. PubMed ID: 30253377
    [Abstract] [Full Text] [Related]

  • 10. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F, Franco T, Topa M, Baldassarre C, Gruppo Responsabili UO Sert T.
    Eur Rev Med Pharmacol Sci; 2011 Aug 01; 15(8):871-4. PubMed ID: 21845796
    [Abstract] [Full Text] [Related]

  • 11. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI, Burt R, Thiede H, Glick SN.
    Subst Abus; 2018 Jan 02; 39(1):83-88. PubMed ID: 28796591
    [Abstract] [Full Text] [Related]

  • 12. Global opioid agonist treatment: a review of clinical practices by country.
    Jin H, Marshall BDL, Degenhardt L, Strang J, Hickman M, Fiellin DA, Ali R, Bruneau J, Larney S.
    Addiction; 2020 Dec 02; 115(12):2243-2254. PubMed ID: 32289189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.
    Winstock AR, Lea T.
    Subst Use Misuse; 2010 Dec 02; 45(1-2):240-52. PubMed ID: 20025451
    [Abstract] [Full Text] [Related]

  • 15. Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.
    Khemiri A, Kharitonova E, Zah V, Ruby J, Toumi M.
    Postgrad Med; 2014 Sep 02; 126(5):113-20. PubMed ID: 25295655
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors affecting noncompliance with buprenorphine maintenance treatment.
    Fareed A, Eilender P, Ketchen B, Buchanan-Cummings AM, Scheinberg K, Crampton K, Nash A, Shongo-Hiango H, Drexler K.
    J Addict Med; 2014 Sep 02; 8(5):345-50. PubMed ID: 25072677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR, Lea T, Sheridan J.
    Int J Drug Policy; 2008 Dec 02; 19(6):450-8. PubMed ID: 18359216
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.